ADVB
Advanced Biomed Inc.
$5.03
+0.13 (+2.65%)
At close · Jul 17
Going-concern doubt
— flagged May 15, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions give rise to substantial doubt as to whether the Company will be able to continue as a going concern.”View the 10-Q filed May 15, 2026
Market Cap
$6.95M
Shares
1,382,133
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$5.03
Open$5.13
Day$4.92–5.25
52W$3.61–16.14
Avg vol 30d22K
Short int15K · 1.1% float · 1.1d
Short vol27%
DataMar 2025–Jul 2026
Filing10-Q · May 15
Up next
FQ1-27 quarter ends
~Sep 30, 2026
Est
filed May 15, 2026
Equibles Rating
blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical
Sell
Momentum
Weak
Sentiment
Neutral
Fundamentals
Weak
Quant / Vol
Very High
Market backdrop
VIX 18.8 · elevated
Equity put/call 0.73
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−18%
below
Price vs 50-day avg
+6%
above
RSI (14)
52
neutral
MACD trend
Negative
52-week position
11%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+6%
trailing
6-month return
−21%
trailing
YTD return
−14%
this year
Relative strength
−29%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $5 › 200d $6 — 200d above 50d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
1.11% of float · ▲ +73.5% MoM · 1.1 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Squeeze score
51
elevated · 0–100
Fundamentals
EPS growth
−14%
Y/Y
Free cash flow
$-5.9M
Valuation
P/E 1.1
below peers
Quant / Vol
risk profile
Volatility
117%
annualized · 1-yr
Max drawdown
−75%
past year
ATR
10.2%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−18%
Bearish
Price vs 50-day avg
+6%
Bullish
RSI (14)
52
Neutral
MACD trend
Negative
Bearish
52-week position
11%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bearish · 1 of 6
Trend (MA cross)
No cross
50d $5 › 200d $6 — 200d above 50d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
1.11% of float · ▲ +73.5% MoM · 1.1 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Price context
position in its 52-week range
52-wk low $4
Now $5 · 11%
52-wk high $16
vs 200-day avg -18%
vs 50-day avg +6%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Diagnostics & Research — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ADVB
this stock
Advanced Biomed Inc.
|
$6.95M | -13.9% | — | 1.1 | 1.1% |
|
TMO
Thermo Fisher Scientific Inc.
|
$197.88B | -8.0% | +0.4% | 29.3 | 1.4% |
|
DHR
Danaher Corp /De/
|
$144.26B | -10.6% | +8.5% | 39.4 | 1.5% |
|
IDXX
Idexx Laboratories Inc /De
|
$44.76B | -16.1% | +10.4% | 41.8 | 2.5% |
|
NTRA
Natera, Inc.
|
$38.87B | +18.5% | -2.8% | — | 4.1% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionShort & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ADVB | -2.5% | +5.9% | -21.2% | +8.2% | -13.9% |
| SPY | -1.5% | +0.3% | +7.8% | -0.5% | +9.0% |
| vs SPY | -1.0% | +5.6% | -29.0% | +8.6% | -22.9% |
Key facts
CIK
1941029
CUSIP
00752P203